E-LIB Suche - Ergebnisse für: Nguyen, Sean T

1

2762. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

2

2752. Outcomes of Patients with Stenotrophomonas maltophili..:

Marcella, Stephen ; Friedman, Bruce ; Cai, Bin...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

2753. Real-World Use of Cefiderocol Treating Non-COVID Pati..:

Cai, Bin ; Zhou, Yun ; Slover, Christine M..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

4

2791. Antimicrobial Activity of Cefiderocol and Comparator ..:

Nguyen, Sean T ; Valencia, Calbert ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

2790. Activity of Cefiderocol and Comparator Agents Against..:

Nguyen, Sean T ; DeJonge, Boudewijn L ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

6

2751. Cefiderocol Use in Treating Patients with Confirmed S..:

Cai, Bin ; Nguyen, Sean T ; Copeland, Jennifer D..
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

7

2761. Activity of Cefiderocol and Comparator Agents Against..:

DeJonge, Boudewijn L ; Nguyen, Sean T ; Bryowsky, Jason J...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

8

Cefiderocol For Injection: Compatibility Testing Using the ..:

Rathod, Dhaval ; Chen, Zhengming ; Slover, Christine M....
Journal of Pharmacy Technology. 39 (2023) 4 - p. 159-163 , 2023

Link: https://doi.org/10.1177/..

9

2112. In vitro Activity of Cefiderocol and Comparator Agent..:

Bryowsky, Jason J ; DeJonge, Boudewijn L ; Nguyen, Sean T...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

10

Systematic review of the impact of appropriate versus inapp..:

Bassetti, Matteo ; Rello, Jordi ; Blasi, Francesco...
International Journal of Antimicrobial Agents. 56 (2020) 6 - p. 106184 , 2020

Link: https://doi.org/10.1016/..

11

692. In Vitro Antibacterial Activity of Cefiderocol Against..:

Rao, Sonia N ; Nguyen, Sean T ; Soriano, Melinda M...
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S313-S314 , 2019

Link: https://doi.org/10.1093/..

12

Meropenem time above the MIC exposure is predictive of resp..:

Kuti, Joseph L. ; Pettit, Rebecca S. ; Neu, Natalie...
Diagnostic Microbiology and Infectious Disease. 91 (2018) 3 - p. 294-297 , 2018

Link: https://doi.org/10.1016/..

13

Population pharmacokinetics of meropenem administered as a ..:

Pettit, Rebecca S. ; Neu, Natalie ; Cies, Jeffrey J....
Journal of Antimicrobial Chemotherapy. 71 (2015) 1 - p. 189-195 , 2015

Link: https://doi.org/10.1093/..

14

Microbiological activity of ceftolozane/tazobactam, ceftazi..:

Kuti, Joseph L. ; Pettit, Rebecca S. ; Neu, Natalie...
Diagnostic Microbiology and Infectious Disease. 83 (2015) 1 - p. 53-55 , 2015

Link: https://doi.org/10.1016/..

15

Lipid‐Lowering Efficacy and Safety After Switching to Ataza..:

Nguyen, Sean T. ; Eaton, Susan A. ; Bain, Amy M....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 28 (2008) 3 - p. 323-330 , 2008

Link: https://doi.org/10.1592/..